Modern genomic techniques and biochemical assays have been used to identify upregulation of the PI3K/mTOR pathway in both pediatric B and T-acute lymphoblastic leukemia (ALL) (3). This evidence concerns the gene PIK3CD and acute lymphoblastic leukemia.